尽管Astera Labs在2025年第四季度的收益超出预期,但由于短期利率的担忧,其股价下跌. Astera Labs beat earnings expectations in Q4 2025 but saw shares drop due to near-term margin concerns.

Astera实验室报告说,2026年2月10日的第四季度结果比预期的要强,在AI和超大规模需求驱动下,收入为58,000埃普西元和2.7558亿美元,逐年上升91.8%。 Astera Labs reported stronger-than-expected fourth-quarter results on February 10, 2026, with $0.58 EPS and $270.58 million in revenue, up 91.8% year-over-year, driven by AI and hyperscaler demand. 该公司将其第1 2026号问题指导意见提高到0.530 - 0.540 EPS美元。 The company raised its Q1 2026 guidance to $0.530–$0.540 EPS. 尽管收入和增长是正数,但在管理层警告近期差值压力和业务开支增加后,股票下跌,从而引发利润的获取。 Despite the positive earnings and growth, shares dropped after management warned of near-term margin pressures and rising operating expenses, triggering profit-taking. 2月16日,该股票开放129.32美元,市场上限为21.84亿美元,P/E比率为106.00。 The stock opened at $129.32 on February 16, with a market cap of $21.84 billion and a P/E ratio of 106.00. 分析师维持“机动购买”共识,目标价格为192.89美元。 Analysts maintain a "Moderate Buy" consensus with a target price of $192.89. 机构投资者拥有公司60.47%的股份,内部投资者持有12.5%的股份。 Institutional investors own 60.47% of the company, while insiders hold 12.5%.